Press Releases Pro Medicus Limited

Equities

Delayed Australian S.E. Other stock markets 06:06:47 09/05/2024 BST			5-day change	1st Jan Change
116.7 ^AUD	+0.33%		+4.09%	+21.77%

05-08	CLSA Upgrades Pro Medicus to Accumulate from Reduce, Price Target is AU$125	MT
04-02	Pro Medicus Limited authorizes a Buyback Plan.	CI

Pro Medicus : Update - Notification of buy-back - PME	13/07/22	PU
Pro Medicus : Update - Notification of buy-back - PME	08/07/22	PU
Pro Medicus : Update - Notification of buy-back - PME	04/07/22	PU
Pro Medicus : Update - Notification of buy-back - PME	20/06/22	PU
Pro Medicus : Update - Notification of buy-back - PME	16/06/22	PU
Pro Medicus : Update - Notification of buy-back - PME	14/06/22	PU
Pro Medicus : Update - Notification of buy-back - PME	10/06/22	PU
Pro Medicus : Update - Notification of buy-back - PME	07/06/22	PU
Morgans rates PME as Add	03/06/22	AQ
Pro Medicus : Update - Notification of buy-back - PME	26/05/22	PU
Pro Medicus : HY2022 Results Presentation	16/02/22	PU
Pro Medicus : CEO Interview - 1H22 results	15/02/22	PU
Pro Medicus : ASX Presentation 2021	22/11/21	PU
Pro Medicus : PME Signs 7-year $40M Contract with Novant Health	01/10/21	PU
Pro Medicus : Appoints Alice Williams as Director	24/08/21	PU
Pro Medicus : Full-Year Results	18/08/21	PU
Pro Medicus : PME Signs Research Collaboration Agreement with Mayo Clinic	03/06/21	PU
Pro Medicus : PME Signs 8-year Contract with The University of Vermont Health Network Inc.	13/05/21	PU
Interview with Dr Sam Hupert, CEO Pro Medicus [ASX: PME]	17/02/21	PU
Pro Medicus : Interim Results	17/02/21	PU

No results for this search